Tandem Diabetes Care, Inc. (TNDM)
21.64
+0.21
(+0.98%)
USD |
NASDAQ |
Aug 31, 13:25
Tandem Diabetes Care Free Cash Flow : -26.62M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.62M |
| March 31, 2026 | -3.64M |
| December 31, 2025 | -29.67M |
| September 30, 2025 | -25.12M |
| June 30, 2025 | -7.757M |
| March 31, 2025 | -3.796M |
| December 31, 2024 | 4.994M |
| September 30, 2024 | -12.55M |
| June 30, 2024 | -39.44M |
| March 31, 2024 | -43.91M |
| December 31, 2023 | -58.61M |
| September 30, 2023 | -39.67M |
| June 30, 2023 | -32.43M |
| March 31, 2023 | -21.94M |
| December 31, 2022 | 16.37M |
| September 30, 2022 | 21.21M |
| June 30, 2022 | 50.36M |
| March 31, 2022 | 73.84M |
| December 31, 2021 | 87.85M |
| September 30, 2021 | 85.10M |
| June 30, 2021 | 61.77M |
| March 31, 2021 | 44.93M |
| December 31, 2020 | -7.625M |
| September 30, 2020 | -6.073M |
| June 30, 2020 | 4.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.499M |
| December 31, 2019 | 22.36M |
| September 30, 2019 | 22.92M |
| June 30, 2019 | 0.052M |
| March 31, 2019 | -4.051M |
| December 31, 2018 | -11.30M |
| September 30, 2018 | -37.61M |
| June 30, 2018 | -52.40M |
| March 31, 2018 | -61.18M |
| December 31, 2017 | -71.85M |
| September 30, 2017 | -75.12M |
| June 30, 2017 | -76.15M |
| March 31, 2017 | -75.67M |
| December 31, 2016 | -70.10M |
| September 30, 2016 | -65.69M |
| June 30, 2016 | -61.48M |
| March 31, 2016 | -66.40M |
| December 31, 2015 | -64.60M |
| September 30, 2015 | -66.97M |
| June 30, 2015 | -65.44M |
| March 31, 2015 | -63.30M |
| December 31, 2014 | -65.96M |
| September 30, 2014 | -66.16M |
| June 30, 2014 | -65.18M |
| March 31, 2014 | -62.64M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DexCom, Inc. | 1.405B |
| Modular Medical, Inc. | -28.04M |
| Senseonics Holdings, Inc. | -97.24M |
| NeuroPace, Inc. | -11.61M |
| Abbott Laboratories | 7.824B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.63M |
| Cash from Investing (Quarterly) | -87.34M |
| Cash from Financing (Quarterly) | 2.154M |
| Free Cash Flow Per Share (Quarterly) | -0.5605 |
| Free Cash Flow to Equity (Quarterly) | -43.20M |
| Free Cash Flow to Firm (Quarterly) | -36.17M |
| Free Cash Flow Yield | -1.80% |